HIV-positive patients who consume cannabis daily have lower levels of neuroinflammation than non-cannabis consuming HIV-positive patients, according to a University of California, San Diego study published this week in the Journal of the International Neuropsychological Society.
Researchers found that HIV-positive subjects who consumed cannabis daily possessed lower levels of chronic inflammation than did HIV-positive subjects who didn’t use cannabis and that the chronic inflammation results of those who used cannabis were similar to those of HIV-negative subjects with no history of cannabis use.